Overview Dividends

(CG) Carlyle - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14316J1088

Private Equity, Real Assets, Credit, Fund

Asset Management & Custody Banks
Market Cap in USD: 22,060m

IPO / Inception: 2012-05-03
Return 12m vs S&P 500: 2.11%

EPS (Earnings per Share)

EPS CAGR: -44.48%
EPS Trend: -37.6%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: -14.21%
Rev. Trend: -3.0%

Last SUE: -0.24
Qual. Beats: 0

Dividends

Dividend Yield	2.37%
Yield on Cost 5y	5.27%
Yield CAGR 5y	8.78%
Payout Consistency	91.5%
Payout Ratio	35.6%

Risk via 5d forecast
Volatility	35.5%
Value at Risk 5%th	57.4%
Relative Tail Risk	-1.82%

Reward TTM
Sharpe Ratio	0.55
Alpha	-4.93
CAGR/Max DD	0.77

Character TTM
Hurst Exponent	0.421
Beta	1.704
Beta Downside	2.141

Drawdowns 3y
Max DD	38.53%
Mean DD	11.67%
Median DD	11.17%

Description: CG Carlyle December 19, 2025

The Carlyle Group Inc. (NASDAQ: CG) is a global investment firm that operates across four primary platforms – Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions – deploying capital through both direct investments and fund-of-fund structures. Its direct-investment mandate spans a wide array of transaction types, including management-led leveraged buyouts, strategic minority stakes, structured credit, distressed assets, and venture-stage financings, targeting sectors ranging from industrial manufacturing and agribusiness to fintech, aerospace, and healthcare.

As of FY 2023, Carlyle reported approximately $426 billion in assets under management (AUM), reflecting a 12 % YoY increase driven largely by strong fundraising in its Real Assets and Private Equity segments. The firm’s revenue mix is roughly 55 % fee-based (management and performance fees) and 45 % investment income, with net income margins hovering around 15 % after adjusting for one-time gains. Key macro drivers for Carlyle’s pipeline include the current low-interest-rate environment that supports leveraged buyouts, heightened corporate-level cash generation fueling divestitures, and growing institutional demand for ESG-aligned infrastructure assets, especially in renewable energy and logistics.

For a deeper, data-rich view of Carlyle’s valuation dynamics and peer comparisons, you may find it worthwhile to explore the analytics on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (661.5m TTM) > 0 and > 6% of Revenue (6% = 221.5m TTM)

FCFTA -0.09 (>2.0%) and ΔFCFTA -8.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -56.75% (prev 83.71%; Δ -140.5pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.09 (>3.0%) and CFO -2.43b <= Net Income 661.5m (YES >=105%, WARN >=100%)

Net Debt (9.40b) to EBITDA (1.15b) ratio: 8.16 <= 3.0 (WARN <= 3.5)

Current Ratio 0.67 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (376.5m) change vs 12m ago 3.02% (target <= -2.0% for YES)

Gross Margin 80.96% (prev 76.77%; Δ 4.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 14.85% (prev 12.98%; Δ 1.87pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.37 (EBITDA TTM 1.15b / Interest Expense TTM 702.9m) >= 6 (WARN >= 3)

Altman Z'' 0.03

(A) -0.08 = (Total Current Assets 4.26b - Total Current Liabilities 6.35b) / Total Assets 27.06b

(B) 0.06 = Retained Earnings (Balance) 1.62b / Total Assets 27.06b

(D) 0.08 = Book Value of Equity 1.62b / Total Liabilities 20.21b

Total Rating: 0.03 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 32.37

1. Piotroski 3.0pt

2. FCF Yield -8.00%

3. FCF Margin -68.19%

4. Debt/Equity 2.25

5. Debt/Ebitda 8.16

6. ROIC - WACC (= -0.70)%

7. RoE 11.67%

8. Rev. Trend -3.01%

9. EPS Trend -37.59%

What is the price of CG shares?

As of January 01, 2026, the stock is trading at USD 59.11 with a total of 949,913 shares traded.
Over the past week, the price has changed by -3.08%, over one month by +9.34%, over three months by -5.09% and over the past year by +20.20%.

Is CG a buy, sell or hold?

Carlyle has received a consensus analysts rating of 3.56. Therefor, it is recommend to hold CG.

Strong Buy: 4
Buy: 3
Hold: 10
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the CG price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	66.3	12.1%
Analysts Target Price	66.3	12.1%
ValueRay Target Price	68.9	16.6%

CG Fundamental Data Overview December 27, 2025

Market Cap USD = 22.06b (22.06b USD * 1.0 USD.USD)
P/E Trailing = 34.264
P/E Forward = 12.2399
P/S = 6.876
P/B = 3.9116
P/EG = 0.838
Beta = 2.055
Revenue TTM = 3.69b USD
EBIT TTM = 962.8m USD
EBITDA TTM = 1.15b USD
Long Term Debt = 12.54b USD (estimated: total debt 12.66b - short term 118.7m)
Short Term Debt = 118.7m USD (from shortTermDebt, last quarter)
Debt = 12.66b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.40b USD (from netDebt column, last quarter)
Enterprise Value = 31.46b USD (22.06b + Debt 12.66b - CCE 3.26b)
Interest Coverage Ratio = 1.37 (Ebit TTM 962.8m / Interest Expense TTM 702.9m)
FCF Yield = -8.00% (FCF TTM -2.52b / Enterprise Value 31.46b)
FCF Margin = -68.19% (FCF TTM -2.52b / Revenue TTM 3.69b)
Net Margin = 17.92% (Net Income TTM 661.5m / Revenue TTM 3.69b)
Gross Margin = 80.96% ((Revenue TTM 3.69b - Cost of Revenue TTM 702.9m) / Revenue TTM)
Gross Margin QoQ = 73.47% (prev 83.10%)
Tobins Q-Ratio = 1.16 (Enterprise Value 31.46b / Total Assets 27.06b)
Interest Expense / Debt = 1.64% (Interest Expense 207.1m / Debt 12.66b)
Taxrate = -31.12% (negative due to tax credits) (-26.7m / 85.8m)
NOPAT = 1.26b (EBIT 962.8m * (1 - -31.12%)) [negative tax rate / tax credits]
Current Ratio = 0.67 (Total Current Assets 4.26b / Total Current Liabilities 6.35b)
Debt / Equity = 2.25 (Debt 12.66b / totalStockholderEquity, last quarter 5.62b)
Debt / EBITDA = 8.16 (Net Debt 9.40b / EBITDA 1.15b)
Debt / FCF = -3.74 (negative FCF - burning cash) (Net Debt 9.40b / FCF TTM -2.52b)
Total Stockholder Equity = 5.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.44% (Net Income 661.5m / Total Assets 27.06b)
RoE = 11.67% (Net Income TTM 661.5m / Total Stockholder Equity 5.67b)
RoCE = 5.29% (EBIT 962.8m / Capital Employed (Equity 5.67b + L.T.Debt 12.54b))
RoIC = 7.89% (NOPAT 1.26b / Invested Capital 16.01b)
WACC = 8.59% (E(22.06b)/V(34.72b) * Re(12.29%) + D(12.66b)/V(34.72b) * Rd(1.64%) * (1-Tc(-0.31)))
Discount Rate = 12.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.15%
Fair Price DCF = unknown (Cash Flow -2.52b)
EPS Correlation: -37.59 | EPS CAGR: -44.48% | SUE: -4.0 | # QB: 0
Revenue Correlation: -3.01 | Revenue CAGR: -14.21% | SUE: -0.24 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.17 | Chg30d=+0.012 | Revisions Net=-1 | Analysts=10
EPS next Year (2026-12-31): EPS=4.80 | Chg30d=+0.027 | Revisions Net=+1 | Growth EPS=+18.2% | Growth Revenue=+24.6%

Additional Sources for CG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle